Delivery Order SPE2DR25D2103-SPE2DR26F91RL
- Not listed
- The Defense Logistics Agency awarded a $1,842.17 delivery order to AmerisourceBergen Drug Corp for Abilify Maintena ER 400 mg syringes, with performance at the contractor's Conshohocken, Pennsylvania headquarters and completion scheduled for September 16, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a child order under AmerisourceBergen's larger pharmaceutical supply vehicle with the DLA. The award reflects the contractor's role as a critical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,256.48 to AmerisourceBergen Drug Corp for the supply of Abilify Maintena ER 400 mg syringes. This firm fixed-price, competitively awarded contract was issued on October 27, 2025, with an ultimate completion date of October 28, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,438.27 for Abilify Maintena ER 400 mg syringes, with an ultimate completion date of August 28, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen's corporate headquarters operates. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,784.79 to AmerisourceBergen Drug Corp for Abilify Maintena ER 400 mg syringes, with an ultimate completion date of October 21, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's existing contract vehicle with the federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Abilify Maintena ER 400 mg vials/syringes with a ceiling value of $1,784.28. This firm fixed-price delivery order, with an ultimate completion date of November 14, 2025, represents a continuation of pharmaceutical support under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a $4,531.06 delivery order to AmerisourceBergen Drug Corp for Abilify Maintena ER 400 mg syringes, with an ultimate completion date of September 12, 2025. This is a firm fixed price contract with no set-aside designation, awarded on a competitive basis. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $1,842.17 to AmerisourceBergen Drug Corp for the supply of Abilify Maintena ER 400 mg syringes. This competitively awarded, firm fixed-price delivery order was issued on October 16, 2025, with an ultimate completion date of October 17, 2025. The award carries no set-aside designation, indicating open competition among qualified vendors. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this...
- The Defense Logistics Agency awarded a delivery order valued at $5,533.12 to AmerisourceBergen Drug Corp for the supply of Abilify Maintena ER 300 mg syringes, with an ultimate completion date of November 6, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The contract was executed on November 5, 2025, with performance to be fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Abilify Maintena ER 300 mg syringes under a firm fixed-price contract valued at $3,147.13. The award, made on September 25, 2025, represents a non-set-aside competitive procurement with an ultimate completion date of September 26, 2025. AmerisourceBergen's Corporate Office in Conshohocken, Pennsylvania will serve as the place of performance for this pharmaceutical delivery. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,842.17 to AmerisourceBergen Drug Corp for the supply of Abilify Maintena ER 400 mg syringes. This firm fixed price contract, awarded on August 1, 2025, with an ultimate completion date of August 4, 2025, represents a competitively awarded, non-set-aside procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- SPE2DR25D2103Indefinite Delivery Contract
- SPE2DR25D2103-SPE2DR26F91RLDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,517.78 to AmerisourceBergen Drug Corp for the supply of Abilify Maintena ER 400 mg syringes, with a completion date of November 21, 2025. This competitively awarded, firm fixed-price contract was issued on November 20, 2025, with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction within the company's broader relationship with the federal government as a critical pharmaceutical distributor for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and running through December 2026. As the prime contractor on this IDC, AmerisourceBergen supplies an extensive range of pharmaceutical products and medical commodities to support military healthcare programs worldwide, including specialty medications, vaccines, and medical devices across multiple therapeutic domains. The company's track record of non-set-aside, competitively awarded contracts demonstrates its capability to fulfill federal procurement requirements for critical medical supplies serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.5k | 11/20/25 |